Across Europe, tuberculosis (TB) is once again raising alarm, particularly the extensively drug-resistant form (XDR-TB), which is proving as deadly as before antibiotics were discovered. A large ...
Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...
Over the last few decades, the development of nasal vaccines has been used to deliver treatment for various diseases, ...
News-Medical.Net on MSN
Common antibiotic can improve survival and neurological outcomes in CNS-TB
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve ...
Researchers at the NUS Yong Loo Lin School of Medicine have discovered that combining doxycycline with standard Tuberculosis (TB) treatment may protect the brain from damage caused by excessive immune ...
Tuberculosis still kills more people each year than any other infectious disease, despite decades of medical progress. But a team of researchers from Texas A&M University and Scripps Research may have ...
A mission to search for the origin-of-life on Titan, Saturn's largest moon, will be aided by University of Otago – Ōtākou Whakaihu Waka researchers ...
Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results